Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

8.855 -0.235 (-2.58%)
Streaming Delayed Price Updated: 3:29 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Nasdaq Bear Market: These 3 Stocks Are Trading Below Their Book Values
Analysts are bullish on all of these stocks. 
Via The Motley Fool
Better Generics Pharmaceutical Stock: Teva or Viatris?
Both have plans to return to growth. 
Via The Motley Fool
Viatris's Ex-Dividend Date Is Wednesday, Here's What You Need To Know
Via Benzinga
2 Undervalued Growth Stocks With Long-Term Prospects That Are Ready to Rise
There's nothing better than getting a bargain that'll pay off for years. 
Via The Motley Fool
4 Analysts Have This to Say About Viatris
Via Benzinga
Why Is Intuitive Machines (LUNR) Stock Up Today?
Intuitive Machines (LUNR) stock is climbing higher on Monday thanks to new coverage from Canaccord analyst Austin Moeller. 
Via InvestorPlace
Is Warren Buffett Going to Buy Tesla (TSLA) Stock?
Warren Buffett and Tesla (TSLA) stock are hot topics among traders on Monday following a series of Tweets about buying the shares. 
Via InvestorPlace
Earnings Preview: Viatris
Via Benzinga
BMO Downgrades Viatris As Its Looks For More Visibility On Next Phase
Via Benzinga
Where Viatris Stands With Analysts
Via Benzinga
VTRS Stock Alert: What to Know as Viatris Appoints New CEO
Viatris (VTRS) stock is in the news Monday after the healthcare company announced Scott Smith is taking over as its next CEO. 
Via InvestorPlace
BioAtla Announces Change in Executive Leadership
From BioAtla, Inc.
Via GlobeNewswire
2 Dividend Stocks to Buy at a Discounted Price In 2023
Their shares are ripe for getting while the getting is good. 
Via The Motley Fool
Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk
US stocks are coming off a lackluster week and early indications suggest a reversal in sentiment in the new trading week. While rising bond yields could be a cause of concern, the recent weakness could... 
Via Benzinga
Stock Analysis: Viatris
In the past year, Viatris’s share price dropped by $2.76, or about 19%. 
Via Talk Markets
Earnings Scheduled For February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
2 Superb Dividend Stocks to Buy Before the Next Bull Market
There might not be an opportunity to get them for much cheaper than now. 
Via The Motley Fool
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later
These pharmaceutical stocks probably won't stay so attractively valued for too much longer. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023
Via Benzinga
NVIDIA To Rally Around Over 30%? Here Are 10 Other Analyst Forecasts For Friday
Keybanc boosted the price target for NVIDIA Corporation (NASDAQ: NVDA) from $220 to $280. Keybanc analyst John Vinh maintained an Overweight rating on the stock. NVIDIA shares fell 1.7% to $216.22 in... 
Via Benzinga
These Are 3 of the Nasdaq's Cheapest Dividend Stocks
These stocks can be good options whether you value dividends or growth. 
Via The Motley Fool
3 Healthcare Stocks That Are Too Cheap to Ignore
Pay attention when stocks have these kinds of low valuations. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
Via Benzinga
2 Superb Dividend Stocks to Buy Today and Hold Forever
These two companies have long runways for growth and decent yields today. 
Via The Motley Fool
3 Dividend Stocks That Are Ridiculously Cheap Right Now
Their valuations are low and their yields are high. 
Via The Motley Fool
Could This New Drug Launch Be a Hit for Viatris?
Viatris and Kindeva Drug Delivery could soon launch a generic version of AstraZeneca's Symbicort. 
Via The Motley Fool
Is Now the Time to Buy 3 of the S&P 500's Cheapest Stocks?
All of these stocks are trading at less than 7 times their future profits. 
Via The Motley Fool
Why These 7 Healthcare Stocks Could Soar in 2023
These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023. 
Via InvestorPlace
Could This Drug News Give a Lift to Eli Lilly Stock?
In November, Eli Lilly received positive news from the U.S. Food and Drug Administration. 
Via The Motley Fool
1 Passive Income Stock to Buy While It's Cheap and 1 to Avoid
Both businesses are well-suited for producing passive income, but only one has the balance sheet and future prospects to make it work. 
Via The Motley Fool
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.